When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
COLL - Collegium Pharmaceutical: Another Quarter Of Record Revenue Reinforces Long Thesis
Collegium Pharmaceutical Inc.
Collegium Pharmaceutical recently reported their Q3 earnings with a beat on EPS and revenue.
Despite some serious COVID-19 headwinds, Collegium was able to record another quarter of growth and increase their cash on hand while paying down debt.
I believe the company has laid the groundwork for a strong 2021 and beyond. As a result, I still see COLL to be worthy of a buy at these prices.